Clik here to view.
PCI Pharma Services位于新罕布什尔州贝德福德的园区顺利通过国际药品监管机构联盟的检查
费城 (美国商业资讯)– 全球领先的合同开发和生产组织（CDMO）PCI Pharma Services (PCI)已成功完成了国际药品监管机构联盟（ICMRA）对其位于新罕布什尔州贝德福德园区的检查。由此，PCI成为首家通过多机构检查流程的药物产品CDMO，此项检查也是ICMRA新推出的合作混合检查试点 (CHIP)...
View ArticleClik here to view.
PCIファーマ・サービシズのニューハンプシャー州ベッドフォード施設が薬事規制当局国際連携組織（ICMRA）の検査を無成功裏に完了
フィラデルフィア （ビジネスワイヤ） —...
View ArticleClik here to view.
European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to...
INCHEON, South Korea Celltrion today announced that the European Commission (EC) has approved the use of SteQeyma® (CT-P43), an ustekinumab biosimilar referencing Stelara®, for the treatment of...
View ArticleClik here to view.
欧盟委员会批准Celltrion的Stelara®（乌司奴单抗）生物仿制药SteQeyma® (CT-P43)用于治疗多种慢性炎症性疾病
韩国仁川 (美国商业资讯)– Celltrion今天宣布，欧盟委员会(EC)已批准以Stelara®为参考的乌司奴单抗生物仿制药SteQeyma®...
View ArticleClik here to view.
Clik here to view.
Transforming the Future of Medicine with RNA-Based Therapies
BOSTON Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every...
View ArticleClik here to view.
Lubrizol在中国上海成立美容研究院
上海 (美国商业资讯)– 全球特种化学领导者Lubrizol今天宣布在中国上海成立美容研究院。该研究机构将作为战略枢纽，进一步提高体内美容测试能力，应用决策科学以实现新一代美容成分，加强创新合作，并为Lubrizol在该地区及其他地区的美容和个人护理客户加快产品上市速度。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Lubrizol Opens Beauty Research Institute in Shanghai, China
SHANGHAI Lubrizol, a global specialty chemistry leader, announced today the opening of its Beauty Research Institute in Shanghai, China. The site will serve as a strategic hub to further grow in...
View ArticleClik here to view.
Capcom’s Monster Hunter Bridge to be Exhibited in the Osaka Healthcare...
OSAKA, Japan Capcom Co., Ltd. (TOKYO:9697) today announced that the company will sponsor the Osaka Healthcare Pavilion, which is being exhibited by the Expo 2025, Osaka Pavilion Promotion Committee...
View ArticleClik here to view.
Rockwell Medical Enters into Multi-Million Dollar Distribution Agreement with...
WIXOM, Mich. Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis...
View ArticleClik here to view.
借助RNA疗法改变医学的未来
美国波士顿 (美国商业资讯)– Novotech（诺为泰）是一家专门与生物技术公司合作、加快各个阶段先进新型疗法的开发、可提供全方位服务的国际性临床合同研究组织 (CRO)。现在诺为泰发布了一份新的行业报告，题为《RNA疗法——全球临床试验概况 (2024)》。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Rapid Medical™报告称在对TIGERTRIEVER™13的DISTALS研究中期安全性分析中未发现中等血管闭塞的安全性问题
以色列约克尼穆、德克萨斯州绍斯莱克和法国马赛 (美国商业资讯)– 领先的先进血管内器械开发商Rapid Medical ™ 在2024年欧洲微创神经治疗学会 (ESMINT) 大会上宣布完成DISTALS研究的中期安全性分析。 “我们很高兴DSMB认为TIGERTRIEVER 13的安全性特征让我们可以继续进行随机化。这体现了它的独特设计优势，由于TIGERTRIEVER...
View ArticleClik here to view.
Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug...
BOSTON Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every...
View ArticleClik here to view.
诺为泰发布2024年胰腺癌全球临床试验和药物开发报告
美国波士顿 (美国商业资讯)– Novotech（诺为泰）是一家专门与生物技术公司合作、加快各个阶段先进新型疗法的开发、可提供全方位服务的国际性临床合同研究组织 (CRO)。现在诺为泰发布了一份新的行业报告，题为《胰腺癌——全球临床试验概况 (2024)》。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Rapid Medical™、TIGERTRIEVER™13を用いたDISTALS臨床試験の中間安全性解析で、中血管閉塞の安全性の懸念がないことを報告
イスラエル・ヨクネアム、テキサス州サウスレイク、フランス・マルセイユ （ビジネスワイヤ） — 先進血管内デバイスの開発で業界をリードするRapid Medical™ は、2024年欧州低侵襲神経治療学会（ESMINT）会議で、DISTALS臨床試験の中間安全性解析が完了したとアナウンスしました。 「TIGERTRIEVER...
View ArticleClik here to view.
MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand...
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the...
View ArticleClik here to view.
MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic...
ALISO VIEJO, Calif. MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro,...
View ArticleClik here to view.
MicroVention更名为Terumo Neuro以反映业务重点扩展和战略增长
加利福尼亚州，阿利索维奥 (美国商业资讯)– MicroVention, Inc.是神经血管创新领域的全球领先企业，也是Terumo Corporation的全资子公司，该公司今天宣布正式更名为Terumo Neuro，即日起生效。此次更名标志着公司的发展翻开了新的篇章，同时也将继续坚定不移地致力于创造神经血管护理领域的突破性创新成果并实现商业化。...
View ArticleClik here to view.
Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The...
MILAN Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives, today announced the online publication of its...
View ArticleClik here to view.
Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus...
KING OF PRUSSIA, PA & SAN DIEGO Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and sa-mRNA pioneer Arcturus Therapeutics today announced that Japan’s Ministry of Health, Labor and...
View Article